TipRanks
Strides Pharma Science Ltd (IN:STAR)
:STAR
India Market
Want to see IN:STAR full AI Analyst Report?

Strides Pharma Science Ltd (STAR) Ratios

3 Followers

Strides Pharma Science Ltd Ratios

IN:STAR's free cash flow for Q4 2026 was ₹0.37. For the 2026 fiscal year, IN:STAR's free cash flow was decreased by ₹ and operating cash flow was ₹0.14. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
1.25 1.25 1.20 1.03 1.08
Quick Ratio
0.68 0.68 0.70 0.64 0.70
Cash Ratio
0.07 0.07 0.05 0.06 0.10
Solvency Ratio
0.22 0.20 0.17 0.04 <0.01
Operating Cash Flow Ratio
0.14 0.19 0.26 0.24 0.01
Short-Term Operating Cash Flow Coverage
0.35 0.48 0.56 0.40 0.03
Net Current Asset Value
₹ -1.65B₹ -1.65B₹ -3.63B₹ -7.99B₹ -12.22B
Leverage Ratios
Debt-to-Assets Ratio
0.25 0.25 0.31 0.43 0.46
Debt-to-Equity Ratio
0.57 0.57 0.74 1.18 1.37
Debt-to-Capital Ratio
0.36 0.36 0.42 0.54 0.58
Long-Term Debt-to-Capital Ratio
0.15 0.15 0.18 0.24 0.34
Financial Leverage Ratio
2.23 2.23 2.37 2.75 3.00
Debt Service Coverage Ratio
0.74 0.74 0.58 0.20 0.29
Interest Coverage Ratio
4.24 4.05 2.08 0.96 0.47
Debt to Market Cap
0.16 0.19 0.29 0.69 2.24
Interest Debt Per Share
209.35 210.09 231.33 311.13 365.31
Net Debt to EBITDA
1.46 1.47 1.88 5.36 5.42
Profitability Margins
Gross Profit Margin
36.74%36.40%26.43%22.23%21.95%
EBIT Margin
17.01%17.44%16.44%5.73%7.09%
EBITDA Margin
21.20%21.60%20.72%11.48%13.71%
Operating Profit Margin
14.53%14.88%11.58%7.88%3.37%
Pretax Profit Margin
14.91%13.76%10.88%-3.00%-7.80%
Net Profit Margin
12.26%11.45%9.06%-1.84%-6.03%
Continuous Operations Profit Margin
12.68%11.82%9.15%-3.76%-6.29%
Net Income Per EBT
82.21%83.18%83.25%61.51%77.29%
EBT Per EBIT
102.64%92.50%93.95%-38.03%-231.54%
Return on Assets (ROA)
8.86%8.03%6.70%-1.21%-3.33%
Return on Equity (ROE)
21.81%17.90%15.88%-3.32%-10.00%
Return on Capital Employed (ROCE)
18.03%17.93%14.99%10.20%3.39%
Return on Invested Capital (ROIC)
11.92%11.98%9.24%6.38%1.87%
Return on Tangible Assets
11.09%10.05%8.22%-1.48%-3.98%
Earnings Yield
5.94%6.43%6.61%-2.01%-17.87%
Efficiency Ratios
Receivables Turnover
3.86 3.75 3.72 3.35 2.60
Payables Turnover
2.42 2.36 3.19 3.50 2.91
Inventory Turnover
1.94 1.89 2.58 2.64 2.50
Fixed Asset Turnover
4.34 4.21 4.57 3.92 2.67
Asset Turnover
0.72 0.70 0.74 0.66 0.55
Working Capital Turnover Ratio
13.95 7.93 14.99 22.33 35.63
Cash Conversion Cycle
132.09 135.84 125.28 142.54 161.12
Days of Sales Outstanding
94.61 97.44 98.11 108.87 140.19
Days of Inventory Outstanding
188.47 193.10 141.63 138.07 146.17
Days of Payables Outstanding
150.99 154.70 114.46 104.40 125.24
Operating Cycle
283.08 290.54 239.73 246.94 286.35
Cash Flow Ratios
Operating Cash Flow Per Share
42.47 58.49 74.38 77.04 4.93
Free Cash Flow Per Share
26.29 13.15 48.02 64.06 -5.61
CapEx Per Share
16.19 45.34 26.36 12.98 10.54
Free Cash Flow to Operating Cash Flow
0.62 0.22 0.65 0.83 -1.14
Dividend Paid and CapEx Coverage Ratio
2.10 1.19 2.58 5.32 0.47
Capital Expenditure Coverage Ratio
2.62 1.29 2.82 5.93 0.47
Operating Cash Flow Coverage Ratio
0.22 0.31 0.36 0.28 0.01
Operating Cash Flow to Sales Ratio
0.08 0.11 0.15 0.18 0.01
Free Cash Flow Yield
2.35%1.40%7.20%16.61%-4.08%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
16.83 15.54 15.14 -49.69 -5.60
Price-to-Sales (P/S) Ratio
2.06 1.78 1.37 0.92 0.34
Price-to-Book (P/B) Ratio
3.32 2.78 2.40 1.65 0.56
Price-to-Free Cash Flow (P/FCF) Ratio
42.61 71.30 13.88 6.02 -24.50
Price-to-Operating Cash Flow Ratio
26.37 16.03 8.96 5.00 27.88
Price-to-Earnings Growth (PEG) Ratio
0.21 0.42 -0.03 0.73 0.11
Price-to-Fair Value
3.32 2.78 2.40 1.65 0.56
Enterprise Value Multiple
11.19 9.71 8.49 13.35 7.89
Enterprise Value
118.68B 101.89B 78.78B 58.65B 39.64B
EV to EBITDA
11.19 9.71 8.49 13.35 7.89
EV to Sales
2.37 2.10 1.76 1.53 1.08
EV to Free Cash Flow
48.98 84.04 17.83 10.06 -78.46
EV to Operating Cash Flow
30.32 18.90 11.51 8.37 89.26
Tangible Book Value Per Share
190.43 190.42 159.97 111.56 121.67
Shareholders’ Equity Per Share
337.15 337.13 277.34 233.57 245.59
Tax and Other Ratios
Effective Tax Rate
0.15 0.14 0.16 -0.25 0.19
Revenue Per Share
542.93 527.11 486.40 420.67 407.20
Net Income Per Share
66.56 60.34 44.05 -7.76 -24.56
Tax Burden
0.82 0.83 0.83 0.62 0.77
Interest Burden
0.88 0.79 0.66 -0.52 -1.10
Research & Development to Revenue
0.00 0.00 0.02 0.00 0.02
SG&A to Revenue
0.22 0.22 0.12 0.04 0.20
Stock-Based Compensation to Revenue
<0.01 0.00 <0.01 <0.01 <0.01
Income Quality
0.60 0.97 1.69 -11.18 -0.17
Currency in INR